DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
hasn't - 1 — - 1 Samir Khleif - 1 King - 1 Khleif - 1 Catalyst - 1 CJNV BioVenture - 1 Georgiamune - 1
Top related locs:
Jordan Verily U.S Germany Paris Barcelona Milan Abu Dhabi
Top related orgs:
Service - 2 Business - 2 Mubadala - 2 Giant Ventures - 1 Opera Tech Ventures - 1 Mubadala Capital - 1 Finch Finance - 1 Space - 1

Search resuls for: "Mubadala Capital"


9 mentions found


☆ Climate-focused insurtech company Arbol just raised a Series B funding round. Here's an exclusive look at the deck the startup used to land $60 million.
  + stars: | 2024-05-20 | by ( Samantha Stokes | ) www.businessinsider.com   time to read: +1 min
The startup just raised a $60 million Series B funding round. We got an exclusive look at the pitch deck the startup used to raise its new round of funding. Sign up for our newsletter to get the latest on the culture & business of sustainability — delivered weekly to your inbox. The startup Arbol just raised $60 million in Series B funding. Giant Ventures and Opera Tech Ventures co-led the round, with Mubadala Capital also participating in the fundraise.
Persons: hasn't Organizations: Service, Giant Ventures, Opera Tech Ventures, Mubadala Capital, Finch Finance, Space, Business
☆ This biotech startup is finding new cancer drugs with $75 million from General Catalyst. Here's the pitch deck Georgiamune used to raise its Series A.
  + stars: | 2024-03-26 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +4 min
Then, at the Georgia Cancer Center at Augusta University, he began the research that would eventually spin off into his first startup, Georgiamune. The same month, Georgiamune also got FDA clearance to begin human clinical trials for its first cancer drug candidate. Georgiamune's primary drug target works to solve a problem posed by another type of cancer drug on the market, called checkpoint inhibitors. For a Series A biotech startup, Georgiamune has an unusually extensive pipeline, with nine biological targets identified internally, all of which use different mechanisms of action than existing drugs. AdvertisementHere's the 21-slide pitch deck Georgiamune used to raise a $75 million Series A co-led by General Catalyst.
Persons: —, Samir Khleif, King, Khleif, Catalyst, CJNV BioVenture, Georgiamune, doesn't, Amy Abernethy, Khleif's, General Catalyst Organizations: Service, King Hussein Cancer Center, Georgia Cancer Center, Augusta University, Business, Parker Institute for Cancer, Mubadala, Alexandria Venture Investments, Catalio Capital Management, Verition Fund Management, Bicara Therapeutics, Therapeutics, General Locations: Jordan, Verily
☆ Deutsche Bank and UniCredit back $4.5 billion insurance startup Wefox with $55 million in fresh funds
  + stars: | 2023-11-03 | by ( Ryan Browne | ) www.cnbc.com   time to read: +2 min
Wefox, the $4.5 billion German insurance technology group, has raised $55 million of fresh funding from Deutsche Bank and UniCredit , two anonymous sources familiar with the deal told CNBC. The deal was structured as a convertible debt agreement, meaning that the debt will be converted into equity when Wefox next raises cash, the sources told CNBC. The fresh funding follows on from a $55 million debt round Wefox raised from JPMorgan and Barclays and a $55 million internal fundraise earlier this year. As Wefox didn't raise equity, its valuation remains unchanged at $4.5 billion. Wefox is also pushing into a new model of selling insurance called "affinity" distribution.
Persons: Wefox, Goldman Sachs Organizations: Deutsche Bank, CNBC, JPMorgan, Barclays, VC, Salesforce Ventures, Target, Horizon Ventures, UBS, Mubadala Capital Ventures, Jupiter Asset Locations: U.S, Germany, Paris, Barcelona, Milan
☆ Mubadala raises stake in Brazilian ethanol producer Atvos
  + stars: | 2023-10-20 | by ( ) www.reuters.com   time to read: 1 min
SAO PAULO, Oct 20 (Reuters) - Abu Dhabi state investor Mubadala Capital raised its stake in Brazilian ethanol producer Atvos, the latter said on Friday. Mubadala, through investment fund FIP MC Green, acquired the stake owned by Grupo Novonor, formerly known as Odebrecht, in the holding company that controls Atvos, representing about 6.85% of the firm's equity. Mubadala already had a direct stake of 31.5% in Atvos. In a statement, the sugarcane ethanol producer said it also aims to enter new markets, such as corn ethanol; biomethane from vinasse and sugarcane straw, in addition to producing sustainable aviation fuel. Reporting by Peter Frontini; Editing by Leslie AdlerOur Standards: The Thomson Reuters Trust Principles.
Persons: Atvos, Green, Mubadala, Peter Frontini, Leslie Adler Organizations: SAO PAULO, Mubadala, FIP, Grupo Novonor, Thomson Locations: Abu Dhabi, Atvos, vinasse
☆ Abu Dhabi's Mubadala to buy majority stake in Fortress Investment from SoftBank
  + stars: | 2023-05-22 | by ( ) www.reuters.com   time to read: +1 min
May 22 (Reuters) - Abu Dhabi's Mubadala Investment Co will acquire a majority stake in U.S. asset manager Fortress Investment Group from Japan's SoftBank Group Corp (9984.T). Financial terms of the deal were not disclosed, Mubadala and Fortress Investment said in a joint statement on Monday. After the completion of the deal, Fortress' management will own a 30% stake in the company, while Mubadala Capital will hold the rest, according to the statement. Fortress management will hold a class of equity that entails it to appoint a majority of seats on the board. Fortress will appoint Drew McKnight and Joshua Pack as co-CEOs and Pete Briger as chairman, the companies said.
☆ The rapid grocery app bubble, inflated by the pandemic, is nearing its endgame
  + stars: | 2023-04-21 | by ( Callum Burroughs | ) www.businessinsider.com   time to read: +4 min
Grocery apps exploded during the pandemic and attained wild, multibillion-dollar valuations. European market leader Getir and smaller rival Flink are both set for big valuation haircuts. That's against a backdrop of grocery startups quitting markets, being acquired, delaying IPO, and going bankrupt. Grocery startups took massive hits as they chased usersWhat happened? Consolidation has come quickly, as smaller startups run into the realities of a low-margin model and find they can't keep up the requisite spend to chase consumers.
☆ 6 startups that have raised $100 million or more in 2023 to change healthcare
  + stars: | 2023-04-11 | by ( Yeji Jesse Lee | ) www.businessinsider.com   time to read: +3 min
The healthcare-staffing startup ShiftKey raised $300 million in a round led by its majority investor Lorient Capital. The clinical-trials-tech startup Paradigm raised a $203 million Series A round led by Arch Venture Partners and General Catalyst. The healthcare-staffing startup ShiftMed raised a $200 million round led by Panoramic Ventures. raised a $200 million round led by Panoramic Ventures. Vytalize Health, a startup that helps doctors provide value-based care, raised $100 million from Enhanced Healthcare Partners, Monroe Capital, and North Coast Ventures.
☆ See the 6 startups that have raised the most cash in 2023 to transform healthcare
  + stars: | 2023-04-05 | by ( Yeji Jesse Lee | ) www.businessinsider.com   time to read: +3 min
Startups in the industry raised $3.4 billion across 132 deals in the first three months of 2023. The healthcare-staffing startup ShiftKey raised $300 million in a round led by its majority investor Lorient Capital. The clinical-trials-tech startup Paradigm raised a $203 million Series A round led by Arch Venture Partners and General Catalyst. The healthcare-staffing startup ShiftMed raised a $200 million round led by Panoramic Ventures. raised a $200 million round led by Panoramic Ventures.
☆ Embark shares tank as autonomous trucking firm mulls 'shutting down completely'
  + stars: | 2023-03-06 | by ( ) www.reuters.com   time to read: +1 min
Investors and industry watchers have also been concerned about billions of dollars that have been poured into the self-driving technology sector in a short span of time to commercialize it. "Over the next handful of weeks, we will work closely with the Embark Board of Directors to evaluate our options, including selling assets, restructuring the company or shutting down completely." Embark went public in 2021 through a special purpose acquisition company (SPAC) deal and is backed by Mubadala Capital, Sequoia Capital and Tiger Global Management. The company expects to incur charges of $7 million to $11 million related to the workforce reduction, which spans about 230 employees. Shares of Embark closed down 32.8% lower at $2.56 on Monday, giving the firm a market capitalization of $60 million, compared with the over $5 billion in market value when it went public.
0 next >>
Total: 9